Elekta AB Release: Year-End Report May – April 2013/14

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

· Order bookings amounted to SEK 12,253 M (12,117), equivalent to an increase of 5* percent.

· Net sales increased 7* percent to SEK 10,694 M (10,339).

· EBITA amounted to SEK 2,183 M (2,297) before non-recurring items of SEK -161 M (-46), equivalent to an increase of 3* percent. Currency effects amounted to SEK -175 M. A program has been launched to further streamline the organization. Non-recurring costs of SEK 100 million related to the program have been expensed in the fourth quarter.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC